Drug Profile
Sameridine
Alternative Names: LPB 139Latest Information Update: 07 May 1999
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaesthesia